ReviewFuture oncology (London, England)2026

GLP-1 receptor agonists and immune checkpoint inhibitor therapy: a narrative review on mechanistic and clinical evidence.

Connor FreyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.